PHOTOTHERAPY VERSUS PREGABALIN IN TREATMENT OF REFRACTORY UREAMIC PRURITIS
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
Patients will be randomly assigned into 2 groups:
1. Group A: (20 patients) will receive NB UVB phototherapy 3 sessions per week for 2
months.
2. Group B: (20 patients) will receive pregabalin oral therapy (50mg after each dialysis
session) for 2 months.